4,4,5,5-Tetramethyl-2-(3,4,5-trimethoxyphenyl)-1,3,2-dioxaborolane, 98%, 5g

1,2-DIHYDRO-3-HYDROXY-2-OXO-4-PYRIDINECARBOXYLIC ACID ETHYL ESTER, 95.0%, 100mg

3-Fluoro-2-methoxybenzonitrile, 95.0%, 1g

Methyl indole-3-carboxylate, 99.0%, 25g

(2,6-Diethyl-4-methylphenyl)boronic acid, 97.0%, 1g

Dichloro(1,5-cyclooctadiene)ruthenium(II), 99.0%, 5g

(E)-3-(3,4-Dichlorophenyl)acrylic acid, 95.0%, 100g

2-Acetylbenzaldehyde, 97%, 1g

6-methyl-1,2,4-triazine-3,5(2H,4H)-dione, 95.0%, 25g

(R)-2-((2-(Hydroxydiphenylmethyl)pyrrolidin-1-yl)methyl)-6-(trifluoromethyl)phenol, 95%, 50mg

4,4'-Diamino-2,2'-bipyridyl>98.0%(GC)(T)200mg

5,5-Dimethylpiperidin-2-one, 95+%, 250mg

Colonne capillaire GC ROTI®Cap-1 MS, 60 m, 0,25 mm, 0,25 µm, 1 pièce(s)